Skip to content

VI Cases

Supporting AstraZeneca to Foster Excellence in Cardiological Treatment

With the digital learning platform MedCampus, AstraZeneca enables cardiologists to share their experiences with colleagues. This contributes to better patient care while intensifying the dialogue between the company and cardiological practitioners.

In times of limited time resources and digital information inflation, it has become more and more difficult for companies to get in touch with their audiences. Pharmaceutical companies in particular face the challenge that physicians inform themselves digitally. The traditional expert dialogue between practitioners and pharmaceutical reps has become harder to establish and maintain.

To strengthen the relationship with cardiologists and reestablish the personal expert dialogue, AstraZeneca asked us to develop a solution supporting interventional cardiologists in their efforts to engage in digital education.

  • 75%
    of target audience use the service

During the research phase of the project, it became clear that the success of the platform would depend on the acceptance of three user groups: Cardiologists using the platform to get informed on treatment innovations and best practices, renowned authorities in the field of interventional cardiology providing high-quality content, AstraZeneca’s pharmaceutical representatives, making the platform known and ensuring access.

In search of a common resonance space, we met and interviewed each of the three user groups to understand their existing pain points, rational and emotional motivations.

The solution we developed included the platform itself and a content creation service for the renowned cardiologist. It served in helping them to document new surgical procedures, discuss complex patient cases, and develop high-quality interactive content formats. The service and the cases became a natural conversation starter for pharmaceutical representatives and cardiologists.

Just a couple of months after launch, MedCampus was being used by 75% of the interventional cardiologist in Germany. 

Curious? Let's have a chat.

Sarah Hartmann

Client Partner